Loading clinical trials...
Loading clinical trials...
An Open-label Study to Evaluate the Pharmacokinetics and Pharmacodynamics and Long-term Safety of Benralizumab Administered Subcutaneously in Children With Severe Eosinophilic Asthma
Conditions
Interventions
Benralizumab
Locations
15
United States
Research Site
Los Angeles, California, United States
Research Site
Orlando, Florida, United States
Research Site
Lincoln, Nebraska, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Coppell, Texas, United States
Start Date
November 21, 2019
Primary Completion Date
September 12, 2022
Completion Date
September 12, 2022
Last Updated
May 18, 2023
Lead Sponsor
AstraZeneca
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions